myo-Inositol transport by a viable rat sciatic-nerve preparation is described. Such 'endoneurial' nerve preparations accumulated myo-inositol by an energy-dependent saturable system. Streptozotocin-diabetes reduced myo-inositol transport into sciatic nerve by approx. 40%. Elevated medium glucose concentration reduced myo-inositol transport into control nerves to a similar extent. Fructose and sorbitol did not inhibit myo-inositol transport. Inclusion of an aldose reductase inhibitor in the medium counteracted the reduced myo-inositol transport caused by elevated glucose concentration. The importance of these results to the problem of diabetic neuropathy is discussed.
Abnormalities of the peripheral nervous system in human diabetes mellitus have been appreciated for many years (Mulder et al., 1961) . A reduction of motor-nerve conduction velocity (MNCV) also occurs in the rat on induction of experimental diabetes with streptozotocin (Sharma & Thomas, 1974; Greene et al., 1975; Jakobsen, 1979; Brown et al., 1980; Thomas et al., 1981) . It is now thought that this peripheral neuropathy in diabetes results from a metabolic abnormality. One such abnormality, decreased free myo-inositol concentration in diabetic rat sciatic nerve, has previously been reported (Greene et al., 1975; Palmano et al., 1977) , and this reduction is consistent with reduced MNCV in acutely diabetic rats (Greene et al., 1975) . myoInositol is the precursor for the inositol-containing phospholipids, which are thought to play an important role in the propagation of nervous impulses (White & Larrabee, 1973; White et al., 1974) . Reduced concentration of total lipid myo-inositol in acutely diabetic rat nerve has been reported from this laboratory (Palmano et al., 1977) , as have alterations in the activities of some enzymes of inositol phospholipid metabolism (Whiting et al., 1979) . Decreased activity of CDP-diacylglycerol: myo-inositol transferase (Clements & Stockard, 1980) and abnormalities in labelling patterns of phosphoinositides (Hothersall & McLean, 1979; Clements & Stockard, 1980; Natarajan et al., 1981; Bell et al., 1982) in diabetic-rat nerve have also been reported.
One study of myo-inositol concentration in human nerve has so far been reported (Dyck et al., 1980) . No reduction was noted in nerve free myo-inositol Vol. 210 concentration in biopsied material from diabetic patients with clinical signs of neuropathy. However, we have recently completed a study of post-mortem sciatic nerve that shows a reduced concentration of free myo-inositol in nerves from diabetics compared with controls (Mayhew et al., 1982) . myo-Inositol is maintained in peripheral nerve at a concentration that greatly exceeds that in serum (Greene et al., 1975; Palmano et al., 1977) . Both synthesis from D-glucose and active accumulation could contribute to this. Synthesis of myo-inositol has been described for a number of tissues (Eisenberg, 1967; Whiting et al., 1979) , but only limited activity is present in rat sciatic nerve (Whiting et al., 1979) . It seems likely then that a mechanism for active accumulation of myo-inositol exists in peripheral nerve. Active transport of myo-inositol has been well characterized for a number of tissues (Hauser, 1965; Broeckhuyse, 1968; Caspary & Crane, 1970; Spector & Lorenzo, 1975; Gryan & Czech, 1979; Hammerman et al., 1980) , but there has, as yet, been no report of peripheral-nerve myo-inositol transport. The present study was designed to utilize a rat sciatic-nerve preparation in vitro to investigate the possibility of such a mechanism, and, if present, to (Fig. 1) .
To make the 'endoneurial' preparation, the 'fascicle' preparation was placed in 8ml of KRB buffer/bovine serum albumin/5 mM-glucose, containing 50pM-myo-inositol. It was not found necessary to include myo-inositol at 500,uM to maintain tissue myo-inositol during preparation and incubation as suggested by . By using watchmakers forceps under a dissecting microscope the perineurial membrane was disrupted and removed from the length of the fascicle.
After a 5 min pre-incubation, the fascicle preparation was incubated in 2 ml of KRB buffer/ bovine serum albumin/20mM-glucose and the endoneurial preparation in KRB buffer/bovine serum albumin/5 mM-glucose/5O0uM-myo-inositol, on a shaking water bath with a gas phase of 02/CO2 Tissue preparationfor analysis
For determination of ATP, phosphocreatine, glucose and myo-inositol, nerves were removed from the incubation medium, blotted dry and immediately frozen in liquid N2. They were then powdered over 6% HCl04 in a glass homogenizer with a glass pestle in a bath of liquid N2 (Lowry & Passonneau, 1972) . Homogenization was completed in thawing HC104 in an ethanol/ice bath at approx. -100C (Lowry & Passonneau, 1972) . Samples were centrifuged at 40C and neutralized with KOH before storage at -800C and analysis.
To determine tissue radioactivity after incubation, nerves were washed briefly in ice-cold incubation medium, blotted dry and immediately frozen and stored at -800C. They were transferred to a freeze-drier with a shelf temperature of -400C and freeze-dried to constant weight. Neutralized HC104 extracts of the tissue were made and, after centrifugation, portions of the supernatant were counted for radioactivity. Medium radioactivity was determined in zinc sulphate/barium hydroxide filtrates (Somogyi, 1945) . To 0.5 ml samples of filtrates 0.5 ml of water and 10ml of scintillation fluid (Fisofluor 1; Fisons, Loughborough, Leics., U.K.) were added for counting in a Packard 3375 liquid-scintillation counter. Correction for counting efficiency of 3H/'4C dual label was achieved by using a Digital PDP 11/05 computer.
From the inulin radioactivity, the radioactivity (d.p.m.) per ml of intracellular fluid was calculated by the method of Fox et al. (1964) . These values 1983 were divided by the total medium radioactivity (d.p.m.) of myo-[2-3H]inositol and multiplied by the amount (nmol) of medium myo-inositol to obtain the amount (nmol) of medium myo-inositol appearing/ ml of intracellular fluid. Chemical determinations ATP and phosphocreatine were determined by enzymic assay (Lowry & Passonneau, 1972 ) using hexokinase (yeast; 2 mg/ml suspension), glucose 6-phosphate dehydrogenase (yeast; 5 mg/ml suspension) and creatine kinase (rabbit muscle; all enzymes were from the Boehringer Corporation, London, U.K.) in an Aminco/Bowman Spectrophotofluorimeter.
Sorbitol was measured in neutralized HC104 extracts by fluorimetric assay using sorbitol dehydrogenase (sheep liver; Sigma) by the method of Clements et al. (1969) .
Glucose and myo-inositol were determined in the neutralized HCl04 extracts by g.l.c. as previously described (Palmano et al., 1977) . Serum glucose concentration was determined by using a Glucose Test-Kit (Boehringer, London, U.K.). Serum myoinositol concentration was determined in barium hydroxide/zinc sulphate precipitates (Clements & Stockard, 1980) . Portions of the supernatant obtained on centrifugation were subjected to g.l.c. as described previously (Palmano et al., 1977) .
Results

Animals
During experiments involving diabetic animals, control rats continued to gain weight, whereas diabetics lost, on average, 10% of their original weight (Table 1) .
Serum glucose was significantly elevated in diabetic animals but diabetes did not induce a significant change in serum myo-inositol concentration (Table 1) .
Nerve preparations
To check the viability of the nerve preparations, some of the estimations suggested by Greene et al. (1979) were made. High-energy phosphate compounds and glucose concentrations were determined before and after incubation of fascicle and endoneurial preparations in their respective media.
No significant changes occurred in fascicle ATP, phosphocreatine or glucose concentrations after a 60 min incubation, although ATP concentration increased (Table 2) . Phosphocreatine concentrations in the endoneurial preparation were found to be significantly decreased (P < 0.05) compared with those of the fascicle preparation, but remained stable during 60 min of incubation. ATP and glucose concentrations rose slightly, but insignificantly, during the incubation (Table 2) . Clearly, the ability of the preparations to maintain myo-inositol concentration during incubation is important in a study of the uptake mechanisms of the compound. During a 60min incubation in the absence of medium myo-inositol, the fascicle myoinositol concentration decreased, though not significantly. The endoneurial preparation, in contrast, not only maintained myo-inositol concentration for 60min of incubation, but also accumulated myoinositol from the medium to increase tissue concentration by 18%. This contrasts with the findings , who showed that rabbit endoneurial preparations required the presence of 500pM medium myo-inositol to maintain nerve myo-inositol concentrations over 120 min of incubation.
myo-Inositol accumulation
After a 60min incubation with myo-[2-3Hlinositol without carrier, the fascicle preparation did not appear to actively accumulate myo-inositol from the medium, since the tissue/medium ratio of radioactivity did not exceed unity [0.63 + The accumulation of myo-inositol from the standard medium into intracellular fluid by the endoneurial preparation proceeded at a constant rate of 2.0nmol/ml of intracellular fluid per min throughout 60min of incubation.
Effect ofmedium myo-inositol concentration
Increasing medium tnyo-inositol concentration resulted in a reduction in the rate of increase of accumulation of myo-inositol by the endoneurial preparation, suggestive of a saturable transport system (Fig. 2) . A plot of the 60min data was made by the method of Eisenthal & Cornish-Bowden (1974) . This revealed a Km for myo-inositol transport of 225pgM and a Vm.. of 9.02nmol of myo-inositol accumulated/ml of intracellular fluid per min. The process appears to be an energydependent one linked to (Na+ + K+)-dependent ATPase activity, since inclusion of 2mM-ouabain in the medium inhibited myo-inositol accumulation by 50% (Table 3) .
myo-Inositol accumulation and diabetes
Since myo-inositol appeared to be concentrated by peripheral nerve by an energy-dependent saturable system, the effect on the system of the metabolic changes that occur during diabetes was investigated. Endoneurial preparations of sciatic nerves of age-matched control rats accumulated myo-inositol from the standard medium into intracellular fluid at approx. 120nmol/ml of intracellular fluid per h, corresponding to a tissue/medium radioactivity ratio of approx. 2.5. Diabetes of 4 months duration resulted in a 40% reduction in this rate (Table 3) Nerves from control animals weighing approx. 300 g accumulated myo-inositol at a similar rate compared with nerves from age-matched controls (Table 3) . Therefore, by additions to the medium, it was possible to investigate factors that might affect the transport during experimental diabetes. Elevated glucose concentrations have been shown to inhibit myo-inositol transport in vitro in other tissues (Hauser, 1965; Broeckhuyse, 1968; Caspary & 1983 Table 4 . Glucose, sorbitol and myo-inositol concentrations in sciatic-nerve endoneurial preparations after incubation Results are means (+ S.E.M.) in pmol/g wet wt. of tissue for the numbers of animals given in parentheses. Significance limits were determined by Student's t test. *, P <0.02, versus control; **, P <0.01, versus control; ***, P <0.001, versus control; t, P < 0.01, versus '30mM-glucose'.
Control Diabetic
Change in medium composition 30mM-Glucose 30mM-Glucose + lOM-Sorbinil Hammerman et al., 1980) . Since increased serum glucose concentration during experimental diabetes also results in increased nerve glucose concentrations (Greene et al., 1975; Palmano et al., 1977) endoneurial preparations were incubated in media with 30mM-glucose. This resulted in an approx. 40% reduction of the rate of myo-inositol accumulation (Table 3 ). This inhibition is relatively specific, since medium containing 30mM-fructose or 30mM-sorbitol did not induce a significant decrease (Table 3) . Indeed, myo-inositol accumulation in the presence of 30mM-sorbitol increased by approx. 25%.
When nerves were incubated in medium containing 30mM-glucose with the addition of an aldose reductase inhibitor at 10,UM 634; Sorbinil;  Pfizer), a significant increase in the rate of myoinositol accumulation compared with nerves incubated with 30mM-glucose alone was observed (Table 3 ). This increased rate was also significantly lower than that obtained when nerves were incubated with only the aldose reductase inhibitor at 10pM in standard medium containing 5mM-glucose. Although the concentration of glucose in the nerves from diabetic animals fell during incubation compared with non-incubated nerves (Table 4) , the increased sorbitol concentration observed in diabetic rat nerves (Palmano et al., 1977) persisted. Incubation of nerves from control animals in medium containing 30mM-glucose resulted in nerve glucose concentrations similar to those observed in diabeticrat non-incubated nerve and sorbitol values approx. 3-fold higher than control values. The addition of aldose reductase inhibitor to the medium prevented this increase in nerve sorbitol concentration (Table  4) . Discussion The development of a metabolically stable preparation of rabbit peripheral nerve that overcame the problems of membrane barriers to the external medium was important to the study of the biochemistry of isolated nerve . In the present paper a modification of this Vol. 210 technique was used to study some aspects of rat peripheral-nerve myo-inositol biochemistry. The rat sciatic fascicle and endoneurial preparations also maintained ATP, phosphocreatine and glucose concentrations during preparation and incubation and seemed suitable for further research. The high concentrations of myo-inositol found in peripheral nerve were also maintained during preparation and incubation and could even be increased by medium supplementation with myo-inositol.
It was immediately evident from the transport experiments that no mechanism for the active translocation of myo-inositol through the perineurial membrane exists, since the tissue/medium ratio of inositol radioactivity in the fascicle preparation did not exceed unity. This, and the demonstration that the fascicle-preparation myo-inositol concentration did not decrease significantly during incubation for 1 h, suggests that impermeability of the perineurial membrane to myo-inositol is the means whereby myo-inositol concentration within the endoneurium is maintained. In contrast, the 7-fold increase in the tissue/medium radioactivity ratio observed when the endoneurial preparation was incubated with tracer myo-inositol indicates that myo-inositol in the extracellular space of the endoneurium is actively removed into cellular elements. This process appears to be a saturable one (Fig. 2) . A saturable myo-inositol transport system is found in other tissues (Caspary & Crane, 1970; Spector & Lorenzo, 1975; Gryan & Czech, 1979; Hammerman et al., 1980) , though not in synaptosomes (Warfield et al., 1978) . Also demonstrated in other tissues is the energy-dependence of the process (Hauser, 1965; Broeckhuyse, 1968; Caspary & Crane, 1970; Gryan & Czech, 1979) ,. and sciatic nerve is no exception, accumulation of myo-inositol into intracellular fluid being sensitive to inhibition of (Na+ + K+)-stimulated ATPase activity with ouabain (Table 3 ).
The decreased rate of myo-inositol accumulation by peripheral nerves from diabetic animals is clearly consistent with the lowered concentration in such nerves. Decreased transport of myo-inositol into diabetic-rat nerve has previously been suggested, since experiments in vivo indicated a diminished space of distribution of myo-[2-3H]inositol (Clements & Stockard, 1980) , and experiments in vitro demonstrated decreased incorporation of myoinositol into phosphatidylinositol in diabetic-rat nerves, which was increased in broken-cell preparations (Hothersall & McLean, 1979 ). An attractive possibility for this defect is an effect on myo-inositol transport of elevated ambient glucose concentrations during diabetes, since inhibition of myo-inositol transport in vitro by glucose has been shown in other tissues (Hauser, 1965; Broeckhuyse, 1968; Caspary & Crane, 1970; Hammerman et al., 1980) . Incubation of the endoneurial preparation in 30mM-glucose medium inhibited myo-inositol accumulation by approx. 37%. The elevation of nerve glucose (by some 400%) during this incubation is consistent with the inhibition of myo-inositol transport into intracellular fluid. However, after incubation of the diabetic-rat nerves in 5mM-glucose medium, the glucose concentration in the nerve was only 74% higher than that in controls instead of the 4-6-fold increase normally seen in diabetic-rat nerves. The high concentration of sorbitol in the nerves from diabetic animals persisted during incubation, suggesting that sorbitol does not readily diffuse from cellular elements of peripheral nerve. Incubation of nerves in 30mM-glucose medium also resulted in elevated nerve sorbitol concentrations, though these were much lower than in nerves of diabetic animals. The increase in sorbitol levels during incubation with 30mM-glucose could be prevented by inclusion of an aldose reductase inhibitor in the medium, and this resulted in a significant improvement in the rate of myo-inositol accumulation by nerves incubated in 30mM-glucose. It is possible, therefore, that a combination of increased nerve glucose and sorbitol concentrations is responsible for the defect in myo-inositol transport in nerves from diabetic rats, though added external sorbitol increases the rate of transport (Table 3) . Much of the free myo-inositol in peripheral nerve is thought to be located in Schwann cells (Kusama & Stewart, 1970) , also a proposed site of aldose reductase activity (Gabbay & O'Sullivan, 1968; Ludvigson & Sorenson, 1980) . Perhaps elevated Schwann-cell sorbitol concentrations during diabetes affect the ability of the cell to concentrate and maintain myo-inositol. Indeed, it has been suggested that accumulation of galactitol in sciatic nerve during galactose feeding results in osmotic changes and lowered myo-inositol concentration without direct inhibition of myoinositol synthesis or uptake (Stewart et al., 1968) . Our experiments do not exclude the possibility that a membrane defect caused by the diabetic state, or directly by streptozotocin, damages the inositol transport system. The present study has not attempted to determine whether the effectiveness of the perineurial membrane as a barrier to the release of endoneurial compounds is affected by diabetes. One study has shown that leakage of myo-inositol from the lens in vitro is increased in diabetes (Wada et al., 1979) . A study of release of preloaded labelled myo-inositol from control and diabetic-rat nerves in vitro may therefore prove useful.
We believe that these results have important implications for peripheral nerve function during diabetes. It is proposed that one factor in the aetiology of diabetic neuropathy may be the reduced myo-inositol accumulation by peripheral nerve and that this is responsible for altered inositol phospholipid metabolism.
The demonstration of a modifiable myo-inositol transport mechanism in peripheral nerve allows steps to be taken to normalize nerve concentrations in vivo. Dietary supplementation in rats has been shown to be successful in this regard (Greene et al., 1975; Jefferys et al., 1978) . In the light of the effect of the aldose reductase inhibitor on myo-inositol concentration reported here, a further study of the effects of this compound in vivo is desirable.
